Adrenal Cushing's Syndrome: Clinical Features and Diagnostic Workup
Key Clinical Features
Adrenal Cushing's syndrome presents with distinctive features that differentiate it from simple obesity, most notably the combination of weight gain with specific physical stigmata and metabolic derangements. 1
Most Specific Clinical Findings
- Abnormal fat distribution in supraclavicular and temporal fossae (highly specific for Cushing's) 2
- Wide purple striae (>1 cm), though absence does not exclude diagnosis 3, 2
- Proximal muscle weakness with difficulty rising from a chair or climbing stairs 2
- Truncal obesity with relatively thin extremities 4
- Facial plethora and moon facies 4
Critical Distinguishing Feature in Children
- Growth deceleration (declining height velocity or decreasing height SDS) combined with weight gain is the most sensitive discriminator from simple obesity in prepubertal children 3, 5
- Not all patients with Cushing's are obese, making growth patterns particularly important in pediatric cases 3
Associated Metabolic Complications
- Hypertension (very common) 4
- Glucose intolerance or diabetes mellitus 4
- Increased susceptibility to infections 4
- Osteoporosis and vertebral fractures 1
Diagnostic Workup Algorithm
Step 1: Exclude Exogenous Glucocorticoid Use
Before any biochemical testing, eliminate all exogenous glucocorticoid exposure, as exogenous steroids are the most common cause of Cushing's syndrome. 3 This includes:
Step 2: Initial Biochemical Screening (Perform 2-3 Tests Simultaneously)
The Endocrine Society recommends performing 2-3 first-line screening tests simultaneously rather than relying on a single test, as no test has 100% diagnostic accuracy. 3, 6
Three Essential First-Line Tests:
Late-Night Salivary Cortisol (LNSC)
24-Hour Urinary Free Cortisol (UFC)
Overnight 1-mg Dexamethasone Suppression Test (DST)
Critical Interpretation Pitfalls:
False positives can occur with: 1
- CYP3A4 inducers (phenobarbital, carbamazepine, St. John's wort) causing rapid dexamethasone metabolism
- Increased cortisol-binding globulin from oral estrogens, pregnancy, or chronic hepatitis
- Pseudo-Cushing's states (severe obesity, uncontrolled diabetes, depression, alcoholism) 6
False negatives can occur with: 1
- CYP3A4 inhibitors (fluoxetine, cimetidine, diltiazem) causing higher dexamethasone levels
- Decreased cortisol-binding globulin (nephrotic syndrome)
Measuring dexamethasone levels concomitantly with cortisol improves test interpretability and reduces false-positive results. 1, 6
Step 3: Confirm Hypercortisolism
- If any screening test is abnormal, repeat 1-2 screening tests to confirm 6
- If all tests are normal, Cushing's syndrome is unlikely 6
- Values in pseudo-Cushing's tend to be mildly elevated; UFC is almost always within 3-fold of normal 1
Step 4: Determine ACTH-Dependent vs. ACTH-Independent (Adrenal) Cushing's
Measure morning (8 AM) plasma ACTH level to differentiate the etiology: 6, 5
Low or undetectable ACTH (<5 ng/L or <1.1 pmol/L) = ACTH-independent (adrenal) Cushing's syndrome 6, 5
- Sensitivity: 68%, Specificity: 100% 5
- This confirms adrenal source of cortisol excess
Normal or elevated ACTH (>5 ng/L or >1.1 pmol/L) = ACTH-dependent Cushing's (pituitary or ectopic) 6, 5
Step 5: Adrenal Imaging for ACTH-Independent Cushing's
Once low ACTH confirms adrenal Cushing's, proceed with adrenal imaging: 6
- Non-contrast CT of adrenal glands is the primary imaging modality 1
- Measure Hounsfield units (HU) to characterize lesions 1
- Lesions with >10 HU require further evaluation 1
Additional Hormonal Testing for Adrenal Lesions:
Screen for excess androgen production when adrenocortical carcinoma (ACC) is suspected or virilization is present: 1
- DHEA-S, testosterone, 17β-estradiol 1
- 17-OH progesterone, androstenedione 1
- ACC is responsible for >50% of androgen hypersecretion cases 1
Step 6: Management Based on Findings
For unilateral cortisol-secreting adrenal masses with clinically apparent Cushing's syndrome, perform unilateral adrenalectomy of the affected gland, preferably via minimally invasive surgery. 1
For mild autonomous cortisol secretion (MACS, formerly subclinical Cushing's): 1
- Younger patients with progressive metabolic comorbidities attributable to cortisol excess can be considered for adrenalectomy after shared decision-making 1
- Patients managed non-surgically require annual clinical screening for new or worsening comorbidities 1
- MACS has low risk of progression to overt Cushing's but contributes to medical comorbidity 1
Special Considerations
Cyclic Cushing's Syndrome
- Consider cyclic Cushing's in cases with inconsistent test results 6
- Scalp-hair cortisol/cortisone analysis helps assess long-term glucocorticoid exposure and detect transient hypercortisolism 8
Pediatric Patients
- Screen children only when unexplained weight gain is combined with declining height velocity or decreasing height SDS 3, 5
- Male predominance in pediatric cases (63% overall, 71% prepubertal) versus female predominance in adults 3
- Refer all children with suspected endogenous Cushing's to tertiary care centers with experienced pediatric endocrinology specialists 3